Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features

Gynecologic Oncology

Volumn 55, Issue 2, 1994, Pages 164-168

  Barakat, Richard R ^a   Wong, George ^b   Curtin, John P ^a   Vlamis, Vaia ^a   Hoskins, William J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0028020104     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1994.1271     Document Type: Article

References (24)

1. Love, R. R. Tamoxifen therapy in primary breast cancer: Biology, efficacy, and side effects, J. Clin. Oncol. 7, 803-815 (1989).
2. Gottardis, M. M., Robinson, S. P., Satyaswaroop, P. G., and Jordan, V. C. Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse, Cancer Res. 48, 812-815 (1988).
3. Killackey, M. A., Hakes, T. B., and Pierce, V. K. Endometrial adenocarcinoma in breast cancer patients receiving antiestrogens, Cancer Treat. Rep. 69, 237-238 (1985).
4. Hardell, L. Tamoxifen as risk factor for carcinoma of corpus uteri (letter), Lancet September 3, 563 (1988).
5. Neven, P., De Muylder, X., Van Belle, Y., Vanderick, G., and De Muylder, E. Tamoxifen and the uterus and endometrium (letter), Lancet 1, 375 (1989).
6. Fornander, T., Cedermark, B., Mattsson, A., Skoog, L., Theve, T., Askergren, J., Rutqvist, L. E., Glas, U., Silfversward, C., Somell, A., Wilking, N., and Hjalmar, M.-L. Adjuvant tamoxifen in early breast cancer: Occurrence of new primary cancers, Lancet January 21, 117-120 (1989).
7. Atlante, G., Pozzi, M., Vincenzoni, C., and Vacaturo, G. Four case reports presenting new acquisitions on the association of breast and endometrial cancer, Gynecol. Oncol. 37, 378-380 (1990).
8. Mathew, A., Chabon, A. B., Kabakow, B., Drucker, M., and Hirschman, R. J. Endometrial carcinoma in five patients with breast cancer on tamoxifen therapy, N. Y. State J. Med. 90, 207-208 (1990).
9. Malfetano, J. H. Tamoxifen-associated endometrial carcinoma in postmenopausal breast cancer patients, Gynecol. Oncol. 39, 82-84 (1990).
10. Magriples, U., Naftolin, F., Schwartz, P. E., and Carcangiu, M. L. High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients, J. Clin. Oncol. 11, 485-490 (1993).
11. Lahti, E., Blanco, G., Kauppila, A., Apaja-Sarkkinen, M., Taskinen, P.T., and Laatikainen, T. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen, Obstet. Gynecol. 81, 660-664 (1993).
12. Seoud, M. A.-F., Johnson, J., and Weed, J. C. Gynecologic tumors in tamoxifen-treated women with breast cancer, Obstet. Gynecol. 82, 165-169 (1993).
13. Elwood, J. M., and Boyes, D. A. Clinical and pathological features and survival of endometrial cancer patients in relation to prior use of estrogens, Gynecol. Oncol. 10, 173-187 (1980).
14. Creasman, W. T. New gynecologic cancer staging, Obstet. Gynecol. 75, 287-288 (1990).
15. Ingelfinger, J. A., Mosteller, F., Thibodeau, L. A., and Ware, J. H. Biostatistics in clinical medicine, Mac Millan, New York (1983).
16. Wilcoxan, F. Individual comparison by ranking methods, Biometrics Bull. 1, 80 (1945).
17. Kaplan, E., and Meier, P. Nonparametric estimation from incomplete observations, J. Am. Stat. Assoc. 53, 457-481 (1958).
18. Mantel, N, Evaluation of survival data and two new rank order statistics arising in its consideration, Cancer Chemother. Rep. 50, 163-170 (1966).
19. Wolf, D. M., and Jordan, V. C. Gynecologic complications associated with long-term adjuvant tamoxifen therapy tor breast cancer, Gynecol. Oncol. 45, 118-128 (1992).
20. Satyaswaroop, P. G., Zaino, R. J., and Mörtel, R. Estrogen-like effects of tamoxifen on human endometrial carcinoma transplanted into nude mice, Cancer Res. 44, 4006-4010 (1984).
21. Gal, D., Kopel, S., Bashevkin, M., Lebowicz, J., Lev, R., and Tancer, M. L. Oncologic potential of tamoxifen on endometria of postmenopausal women with breast cancer: Preliminary report, Gynecol. Oncol. 42, 120-123 (1991).
22. Creasman, W. T., Morrow, C. P., Bundy, B. N., Homesley, H. D., Graham, J. E., and Heller, P. B. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group study, Cancer 60, 2035-2041 (1987).
23. Adami, H.-O., Krusemo, U. B., Bergkvist, L., Persson, I., and Pettersson, B. On the age-dependent association between cancer of the breast and of the endometrium. A nationwide cohort study, Br. J. Cancer 55, 77-80 (1987).
24. Steinberg, K. K., Thacker, S. B., Smith, S. J., Stroup, D. F., Zack, M. M., Flanders, W. D., and Berkelman, R. L. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. J. Am. Med. Assoc. 265, 1985-1990 (1991).